Legal News

The Tech M&A Leaders’ Survey is a joint effort by Morrison & Foerster and 451 Research to take the temperature of company executives, corporate development officers, lawyers, bankers, and other dealmakers focused on the technology sector. The mission...By: Morrison & Foerster LLP

For international investors looking at opportunities in China, this summer has been largely a waiting game. Investors have been waiting and hoping as the Chinese government and the Trump administration continue their discussions aimed at resolving...By: Morrison & Foerster LLP

The latest in a string of U.S. government (USG) actions restricting the use of Chinese technology in the U.S. supply chain is an interim rule issued by the Department of Defense (DoD), General Services Administration (GSA), and National Aeronautics...By: Morrison & Foerster LLP - Government

Employment Law Commentary Blog - Many employers have long used noncompetition agreements, or noncompetes, as an important tool for preventing former employees from unfairly competing against them. Although only a few states outright ban noncompetes...By: Morrison & Foerster LLP

On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...By: Morrison & Foerster LLP

On June 7, 2019, an en banc Ninth Circuit panel affirmed certification of a nationwide settlement class and held, 8-3, that class certification criteria are applied less strictly in a settlement context.  Hyundai II preserves the ability to certify...By: Morrison & Foerster LLP - Class Dismissed

A New York federal court recently dismissed a putative class action alleging that a line of dog food products was improperly labeled as “natural” where the plaintiff alleged that the products contained only trace amounts of glyphosate, an herbicide....By: Morrison & Foerster LLP - Class Dismissed

On June 3, 2019, the California Office of Administrative Law (OAL) announced that it had approved a regulation proposed by the Office of Environmental Health Hazard Assessment (OEHHA) that would exempt businesses from having to provide Proposition 65...By: Morrison & Foerster LLP

The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption.  In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...By: Morrison & Foerster LLP - Class Dismissed